Affordable Access

Publisher Website

Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL) and sFas/FasL ratio in patients with bacteremia: A prospective cohort study

Authors
Journal
Journal of Infection
0163-4453
Publisher
Elsevier
Volume
64
Issue
3
Identifiers
DOI: 10.1016/j.jinf.2011.12.006
Keywords
  • Bacteremia
  • Soluble Fas
  • Fas Ligand
  • Sfas/Fasl
  • Sepsis
  • Case Fatality
  • Disease Severity
  • Outcome
  • Apoptosis
Disciplines
  • Biology

Abstract

Summary Background Recent studies have shown that immunoparalysis and lymphocyte apoptosis play a critical role in severe bacteremia. Monitoring apoptosis on a routine basis in septic patients has proved challenging. We here studied the prognostic value of apoptosis markers human soluble Fas (sFas), Fas ligand (FasL) and sFas/FasL ratio in patients with bacteremia. Methods sFas (ng/ml) and FasL (ng/ml) concentrations in plasma were determined using commercial quantitative enzyme immunoassays (Quantikine®, R&D Systems Inc., Minneapolis, MN, USA) in 132 patients with bacteremia caused by Staphylococcus aureus, Streptococcus pneumoniae, β-hemolytic streptococcae or Escherichia coli. Results Maximum sFas, minimum FasL and high sFas/FasL ratio predicted high SOFA score in bacteremic patients (p < 0.001, p = 0.003 and p < 0.001, respectively). AUCROC's in the prediction of high SOFA score for sFas, FasL and sFas/FasL ratio were 0.70 (CI 0.61–0.79), 0.65 (CI 0.56–0.75) and 0.72 (CI 0.63–0.80), respectively. High sFas concentrations and sFas/aFasL ratio, assessed using ROC curve as regards high SOFA (≥4) score, were associated with hypotension (p = 0.001 and p = 0.039, respectively). All of these markers predicted a high SOFA score independently in a logistic regression model. Maximum sFas, sFas/FasL ratio or minimum FasL during days 1–4 after blood culture were not associated with increased case fatality. Conclusions Apoptosis markers sFas, FasL or sFas/FasL ratio are associated with high SOFA score in bacteremia.

There are no comments yet on this publication. Be the first to share your thoughts.